Wainua (eplontersen)
pCPA File Number:
22906
Negotiation Status:
Active Negotiation
Indication(s):
Polyneuropathy in hereditary transthyretin-mediated amyloidosis
Sponsor/Manufacturer:
AstraZeneca Canada Inc.
CDA-AMC Project Number:
SR0826-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable